28 November 2023FeaturesAmericasDaniel Sanchez and Karla Olvera

Patent term compensation controversies in Mexico

Prior to November 5, 2020, Mexican laws and regulations did not provide any mechanism for patent term adjustment for unreasonable delays by the granting authority, the Mexican Institute of Industrial Property (IMPI).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Room for improvement: enforcing data exclusivity provisions in Mexico

16 October 2013 In Mexico, it can be tricky to protect data exclusivity, but prospective international agreements may provide a solution, as Jose Trigueros explains.

Americas

Patent term restoration and adjustment in Mexico: a TPP possibility?

30 April 2013 Patent term restoration has been adopted by several jurisdictions, with varying success. Mexico faces several issues with sanitary authorisations and patent examination, so patent term restoration would be a viable remedy for patent holders. The TPP might enable this.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Trump’s march-in rights threat: Why pharma is rethinking collaborations

GSK escalates mRNA COVID-19 vaccine dispute

Patent term compensation controversies in Mexico

More on this story

Editor's picks

Editor's picks

More features